ResMed buys mementor
By HME News Staff
Updated 10:31 AM CDT, Tue August 2, 2022
MARTINSRIED and LEIPZIG, Germany – ResMed has acquired Leipzig, Germany-based mementor in a move that strengthens its overall sleep portfolio with a digital solution for insomnia, the company says.
mementor developed and owns somnio, Germany’s first, and so far only, Digital Health Application (DiGA) for the treatment of insomnia that’s reimbursable.
“mementor is an ideal fit for ResMed Germany and, more important, millions of people across Germany who want to improve their sleep and overall health,” said Katrin Pucknat, president at ResMed Germany. “The founders have identified a large and neglected area of healthy sleep with an opportunity to help millions of people solve their chronic sleep issue with an easy-to-use digital at-home solution. We look forward to working with the team at mementor to help even more people in Germany achieve good, healthy sleep.”
mementor will be integrated into ResMed in Germany as a separate business segment and will serve as a platform for further developments in the field of digital health. The business segment will be co-led by mementor co-founder and CEO Dr. Noah Lorenz and Katherina Jekerle, who was previously ResMed Germany’s senior marketing director and member of the German leadership team.
The financial terms of the transaction were not disclosed.
Comments